Oka S, Ueda-Akagi Y, Mitsuyoshi T, Ono K, et al. Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment. Leuk Lymphoma 2025 Dec 25:1-6. doi: 10.1080/10428194.2025.2604566.
PMID: 41447515